Modzelewski Katherine L, Stockman Mary-Catherine, Steenkamp Devin W
1 Section of Endocrinology, Diabetes and Nutrition, Boston Medical Center, Boston, MA, USA.
J Diabetes Sci Technol. 2018 Mar;12(2):389-392. doi: 10.1177/1932296817733007. Epub 2017 Sep 27.
Mobile health (mHealth) is an emerging branch of medicine that utilizes technology to impact health care. With increasing access to smartphones and mobile devices, there has been an increase in both the availability and use of mHealth resources, including the use of text messages, apps, and web portals. In diabetes, there is particular interest as technology has long been a mainstay of management through glucometers, insulin pumps and continuous glucose monitors, which are increasingly interconnected. Although there is high demand for mHealth interventions in diabetes, there is no clear consensus on the best way to monitor these interventions. While randomized controlled trials are considered the gold standard for most medical research, we propose that alternative trial designs may be more applicable in the ever-changing mHealth landscape.
移动健康（mHealth）是医学的一个新兴分支，它利用技术来影响医疗保健。随着智能手机和移动设备的普及，mHealth资源的可用性和使用都有所增加，包括短信、应用程序和网络门户的使用。在糖尿病领域，人们对其尤为关注，因为长期以来，技术一直是糖尿病管理的主要手段，如血糖仪、胰岛素泵和持续葡萄糖监测仪，而且这些设备之间的互联性越来越高。尽管糖尿病患者对mHealth干预措施的需求很高，但对于监测这些干预措施的最佳方法尚无明确共识。虽然随机对照试验被认为是大多数医学研究的金标准，但我们认为，在不断变化的mHealth领域，其他试验设计可能更适用。
